Alliancebernstein L.P. Tg Therapeutics, Inc. Transaction History

Alliancebernstein L.P.

  • $280 Billion
  • Q4 2024

A detailed history of Alliancebernstein L.P. transactions in Tg Therapeutics, Inc. stock. As of the latest transaction made, Alliancebernstein L.P. holds 174,020 shares of TGTX stock, worth $7.11 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
174,020
Previous 193,570 10.1%
Holding current value
$7.11 Million
Previous $4.53 Million 15.71%
% of portfolio
0.0%
Previous 0.0%

Shares

21 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 12, 2025
SELL
$21.31 - $35.09 $416,610 - $686,009
-19,550 Reduced 10.1%
174,020 $5.24 Million
Q3 2024

Nov 14, 2024
BUY
$17.21 - $25.28 $545,557 - $801,376
31,700 Added 19.58%
193,570 $4.53 Million
Q2 2024

Aug 14, 2024
SELL
$13.32 - $19.19 $71,262 - $102,666
-5,350 Reduced 3.2%
161,870 $2.88 Million
Q4 2023

Feb 14, 2024
BUY
$6.68 - $18.81 $29,392 - $82,764
4,400 Added 2.7%
167,220 $2.86 Million
Q2 2023

Aug 15, 2023
BUY
$15.48 - $35.0 $80,805 - $182,700
5,220 Added 3.31%
162,820 $4.04 Million
Q1 2023

May 15, 2023
SELL
$10.23 - $19.34 $23,529 - $44,482
-2,300 Reduced 1.44%
157,600 $2.37 Million
Q4 2022

Feb 14, 2023
BUY
$5.01 - $11.83 $15,030 - $35,490
3,000 Added 1.91%
159,900 $1.89 Million
Q1 2022

May 13, 2022
SELL
$7.81 - $20.45 $472,895 - $1.24 Million
-60,550 Reduced 27.85%
156,900 $1.49 Million
Q4 2021

Feb 14, 2022
SELL
$15.2 - $35.51 $314,199 - $734,027
-20,671 Reduced 8.68%
217,450 $4.13 Million
Q3 2021

Nov 10, 2021
BUY
$21.78 - $40.45 $150,695 - $279,873
6,919 Added 2.99%
238,121 $7.93 Million
Q2 2021

Jul 30, 2021
BUY
$32.5 - $48.96 $417,690 - $629,233
12,852 Added 5.89%
231,202 $8.97 Million
Q1 2021

May 06, 2021
SELL
$41.61 - $54.3 $2.61 Million - $3.41 Million
-62,734 Reduced 22.32%
218,350 $10.5 Million
Q4 2020

Feb 08, 2021
BUY
$25.27 - $54.9 $1.64 Million - $3.56 Million
64,884 Added 30.01%
281,084 $14.6 Million
Q3 2020

Nov 12, 2020
SELL
$18.49 - $27.24 $62,200 - $91,635
-3,364 Reduced 1.53%
216,200 $5.79 Million
Q2 2020

Aug 13, 2020
BUY
$8.9 - $21.84 $984,909 - $2.42 Million
110,664 Added 101.62%
219,564 $4.28 Million
Q1 2020

May 14, 2020
SELL
$7.14 - $15.99 $10,995 - $24,624
-1,540 Reduced 1.39%
108,900 $1.07 Million
Q2 2019

Aug 14, 2019
SELL
$6.27 - $8.65 $76,494 - $105,530
-12,200 Reduced 9.95%
110,440 $955,000
Q4 2018

Feb 13, 2019
BUY
$3.44 - $5.76 $137,944 - $230,976
40,100 Added 48.58%
122,640 $503,000
Q3 2018

Nov 08, 2018
BUY
$5.15 - $14.0 $102,485 - $278,600
19,900 Added 31.77%
82,540 $462,000
Q2 2018

Aug 13, 2018
BUY
$12.5 - $15.0 $33,750 - $40,500
2,700 Added 4.5%
62,640 $824,000
Q3 2017

Nov 13, 2017
BUY
$10.0 - $12.7 $599,400 - $761,238
59,940
59,940 $710,000

Others Institutions Holding TGTX

# of Institutions
372
Shares Held
85.5M
Call Options Held
3.78M
Put Options Held
3M
View Full List

About TG THERAPEUTICS, INC.

TGTX Quotes by TradingView
  • Ticker TGTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 145,274,000
  • Market Cap $5.93B
  • Description
  • TG Therapeutics, Inc., a commercial stage biopharmaceutical company, focuses on the acquisition, development, and commercialization of novel treatments for B-cell malignancies and autoimmune diseases. Its therapeutic product candidates include Ublituximab, an investigational glycoengineered monoclonal antibody for the treatment of B-cell non-hod...
More about TGTX
Track This Portfolio

Track Alliancebernstein L.P. Portfolio

Follow Alliancebernstein L.P. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Alliancebernstein L.P., based on Form 13F filings with the SEC.

News

Stay updated on Alliancebernstein L.P. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email